<DOC>
	<DOCNO>NCT01192438</DOCNO>
	<brief_summary>The purpose study evaluate safety MRI-guided laser-induced thermal therapy biopsy confirm low-risk prostate cancer .</brief_summary>
	<brief_title>Laser Based Focal Ablation Low Grade Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Male , 45 year age old Diagnosis prostate adenocarcinoma Clinical stage T1c T2a Gleason score 7 less A minimum 12 biopsy core sample diagnostic biopsy Three few biopsy core prostate cancer No single biopsy core great 50 % tumor involvement A radiographically visible prostate lesion MRI concordance biopsy sextant A documented Karnofsky performance status least 70 Estimated survival 20 year great , determine treat physician Ability give inform consent Previous surgery , radiation , androgen deprivation therapy prostate cancer Presence condition ( e.g. , metal implant , shrapnel ) compatible MRI History previous pelvic radiation Severe low urinary tract symptom measure International Prostate Symptom Score ( IPSS ) 20 great . ( See Appendix A ) History primary nonskin malignancy within previous three year</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>prostate</keyword>
	<keyword>cancer</keyword>
	<keyword>ablation</keyword>
	<keyword>laser-induced</keyword>
	<keyword>focal therapy</keyword>
</DOC>